Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Breast 1

Conditions

Endometrial Neoplasms 4Uterine Cervical Neoplasms 2Myofibroma 2Leiomyoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Carcinoma, Ovarian Epithelial 1

Interventions

Surveys and Questionnaires 4trastuzumab deruxtecan 1apixaban 1X-Rays 1Surgical Procedures, Operative 1Rivaroxaban 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Observation 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Immunotherapy 1Hysterectomy 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heparin, Low-Molecular-Weight 1Hematologic Tests 1Drug Therapy 1Chemoradiotherapy 1CA-125 Antigen 1Buthionine Sulfoximine 1Brachytherapy 1Biological Therapy 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Vaginal Neoplasms × Hysterectomy × Clear all
NCT00005095 2025-02-28

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Northwestern University

Recruiting
6,000 enrolled
BreastGynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Myofibroma, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡